Citigroup Maintains Neutral on Insulet, Lowers Price Target to $319
Portfolio Pulse from richadhand@benzinga.com
Citigroup analyst Joanne Wuensch has maintained a Neutral rating on Insulet (NASDAQ:PODD) and lowered the price target from $330 to $319.

July 11, 2023 | 2:42 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Citigroup has maintained a Neutral rating on Insulet and lowered the price target from $330 to $319.
The news directly pertains to Insulet (PODD) as Citigroup has maintained a Neutral rating on the company and lowered the price target. This could potentially influence investor sentiment and impact the stock's price, although the direction of the impact is uncertain due to the neutral rating.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100